Event Schedule
Theme Day 1: Emerging Technologies, AI & Next-Generation Platforms in Drug Discovery
8:00 – 8:50
Welcome Coffee, Registration & Itinerary Collection
8:50 – 9:00
Soroush Safaei
Senior Principal Scientist
Sanofi
Chair Welcome Address
9:00 – 9:20
Olivier Querolle
Senior Director Medicinal Chemistry
FoRx Therapeutics AG
Opening Keynote: Discovery of Covalent PARG Inhibitors through Scaffold Hopping and the Use of an Underexplored Bicyclo [1.1.0] Butane Carboxamide Warhead
AI & Digital Discovery Frontiers
9:20 - 9:40
Martin Schwill
Head of Artificial Intelligence, Bioinformatics, Computer Aided Drug Discovery
Adularia
Talk 1: PINO-GPT: Physics-Informed Generative GPT Models for Drug Discovery
9:40 - 10:00
Amir Feizi
Head of Translational AI & Target Discovery
Gero
Talk 2: Human-Evidence Target Discovery for Complex Diseases: Foundational Longitudinal Model Reveals Novel Targets in Metabolic Diseases
10:00 – 10:20
James (Jim) Damewood, Ph.D., DABT, ERT
Senior Toxicology Advisor
Affygility Solutions
Partner Slot 1: Occupational Health Categorization for Early Stage Compounds with Limited Data
10:20 - 11:10
Coffee Break
11:10 – 11:30
Elizaveta Solovyeva
Associate Director and Sr Principle Data Scientist
Novartis Biomedical Research
Talk 3: AI for Immunogenicity Prediction of Biologics
11:30 - 12:00
Causaly Ltd
Partner Slot 2: TBC
12:00 - 12:40
Moderator:-
Peyman Gifani
Founder and CEO
AI VIVO
Interactive Panel: The Exponential R&D Organization: Leading Life Sciences Through Agentic AI, Quantum Computing, and the Path to AGI-for-Bio
Panellists:-
Mohamed-Ramzi TEMANNI, PhD
Life Sciences, AI and Innovation Strategy Expert
Amir Feizi
Head of Translational AI & Target Discovery
Gero
Ricardo Gaminha Pacheco
Longevity Biotechnology Strategic Partnering, BD & L Senior Director
Insilico Medicine
12:40 – 13:00
Peyman Gifani
Founder and CEO
AI VIVO
Talk 4: AI-Driven Organisms Level Drug Discovery
13:00 - 14:00
Networking Lunch
14:00 – 14:20
Stanislaw Adaszewski
Computational Neuroscientist
Deep Dive Session: Harnessing Generative AI, NLP, and Advanced Analytics to Accelerate Drug Discovery and Improve Decision-Making
14:20 - 14:45
Sumit Chaudhary
Senior Director - Biology
Sai Life Sciences
Partner Slot 3: A Translational Preclinical Platform for the Evaluation of Emerging IBD Therapeutics
14:45 – 15:05
Krzysztof Brzozka
Chief Scientific Officer, Executive Vice President
Ryvu Therapeutics
Talk 5: From Target Discovery to Next-Generation Therapeutics: Ryvu's Integrated Approach
15:05 - 15:55
Coffee Break
Novel Modalities in Chemistry & Beyond
15:55 - 16:15
Jürg Gertsch
Professor of Pharmaceutical Biology and Biochemistry
University of Bern
Talk 6: Innovating Drug Discovery in the Endocannabinoid System
16:15 – 16:55
Panel Discussion: Small Molecule Drug Discovery or New Modalities in Small Molecule Drugs
Panellists:-
Heena Khatter
Principal Scientist
Roche
Mamta Chabria
CEO
Tandem Therapeutics AG
Vijay Chandrasekar
Associate Principal Scientist
Astrazeneca
Dr Dragan Urosevic, MD MBA
Senior Global Program Medical Director
Novartis
16:55 - 17:00
End of Day 1 with Closing Remarks
Theme Day 2 – Translational Innovation & the Future of Drug Discovery
8:00 – 8:40
Welcome Coffee, Registration & Itinerary Collection
8:40 – 8:45
Soroush Safaei
Senior Principal Scientist
Sanofi
Chair Welcome Address
8:45 – 9:10
Najy Alsayed MD, M.Sc.
Global Therapeutic Area Head - Infectious Diseases
A. Menarini GmbH
Morning Keynote: Bridging Science and Strategic Drug Development: Accelerating Innovation from Discovery to Patient Impact
9:10 - 9:30
Nirnith Devireddy
Founder and CEO
InSilicoMinds
Partner Slot 4: AI-Driven Drug Discovery and Model-Informed Drug Development (MIDD): From Models to Medicines
9:30 - 9:50
Maria Van Dongen
Chief Executive Officer & Co-founder
Allegria Therapeutics
Talk 7: Mastering Mast Cells
9:50 - 10:10
Dr. Stefan Schiesser
Director of Medicinal Chemistry
AstraZeneca
Talk 8: Modulating Disease with Small Molecule RNA Binder - The Next Frontier in Drug Discovery?
10:10 - 11:00
Coffee Break
11:00 – 11:20
Dave Drodge
Group Lead Digital Transformation AI & Digital Marketing
Roche
Talk 9: AI, You, and the Future of Work
11:20 – 11:40
Dr. Bebeka Cosandey
Lead Scientific Program Manager
University Hospital Basel
Deep Dive Session: Clinnova: A Federated Data Infrastructure Accelerating Translational Drug Discovery Across Europe
11:40 – 12:00
Santosh Krishna Subramanian
Scientific Business Development Europe & SE Asia
intoDNA
Partner Slot 5: From DDR Biology to Clinical Decisions: Single-Cell Resolution for DNA Damage & Replication Stress
12:00 – 12:20
Professor Kamalinder K Singh
Chair in Pharmaceutical Technology and Drug Delivery
School of Pharmacy and Biomedical Sciences, University of Central Lancashire
Power Talk: LNPs for RNA Therapeutics More Specifically siRNA
12:20 – 12:40
Stefanie Flückiger-Mangual
CEO and Co-founder
TOLREMO Therapeutics AG
Featured Presentation: Targeting Drug Resistance: Novel Epigenetic Strategies for Next-Generation Cancer Therapies
12:40 – 13:00
Robert Z. Mamoun
CEO
Ciloa SAS
Talk 10: Adiponectin-EVs: Next-Generation Metabolic Disease Therapy
13:00 - 14:00
Lunch Break
14:00 – 14:20
Marcel Blommers
CSO
Saverna Therapeutics AG
Talk 11: Drugging the Undruggable: AI-Guided NMR Discovery of Small Molecules for RNA and Challenging Targets
14:20 – 14:45
Xinlai Cheng
Principal Investigator
Goethe-University Frankfurt am Main
Talk 12: Drugging Spliceosome Fidelity: Discovery of First-in-Class USP39 Degraders for Precision Oncology
14:45 - 15:05
Alexander Rau
Senior Scientist Protein Engineering
ANAVEON
Talk 13: ANV200, an Fc-engineered anti-PD-1 antibody, mediates deep depletion of PD-1–expressing human T cells and limits disease in a xenogeneic GvHD model
15:05 - 15:55
Coffee Break
Future Outlook & Closing
15:55 – 16:15
Yann Abraham
Head of Drug Discovery
DeepLife
Talk 14: Target Identification with Virtual Cells: Using Large Causal Cell Models in Early Drug Discovery
16:15 - 16:35
Manda Pasarka
Global Regulatory Affairs CMC HEAD
Sanofi
Talk 15: Key Considerations: Accelerating Innovation: From First in Human Trials to Regulatory Approval
16:35 - 17:00
Moderator:-
Gisela Soledade Ferreira Andrade
Guest Lecturer
FHNW
Panel Discussion: Discovery 2030: Transforming Innovations into Market Opportunities Through Entrepreneurship
Panellists:-
Ricardo Gaminha Pacheco
Longevity Biotechnology Strategic Partnering, BD & L Senior Director
Insilico Medicine
Sreekanth Gattu
Global Program Head
Sandoz
17:00 - 17:05